메뉴 건너뛰기




Volumn 115, Issue 2, 2007, Pages 143-145

Hydroxyurea associated leg ulcer succesfully treated with hyperbaric oxygen in a diabetic patient

Author keywords

Diabetes; Hydroxyurea; Leg ulcer

Indexed keywords

ANTIBIOTIC AGENT; HYDROXYUREA; PSEUDOMONIC ACID;

EID: 33947162544     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-956164     Document Type: Article
Times cited : (3)

References (17)
  • 1
    • 0032778663 scopus 로고    scopus 로고
    • Leg ulcers and hydroxyurea: Forty-one cases
    • Sirieix ME, Debure C, Baudot N et al.: Leg ulcers and hydroxyurea: forty-one cases. Arch Dermatol 1999; 135 (7):818-820
    • (1999) Arch Dermatol , vol.135 , Issue.7 , pp. 818-820
    • Sirieix, M.E.1    Debure, C.2    Baudot, N.3
  • 3
    • 0032406759 scopus 로고    scopus 로고
    • Leg ulcer associated with hydroxyurea treatment in a patient with chronic myelogenous leukaemia: Successful treatment with prostagladin E1 and pentoxifylline
    • Kido M, Togo O, Fujiwara H, Ito M, Niwano H: Leg ulcer associated with hydroxyurea treatment in a patient with chronic myelogenous leukaemia: successful treatment with prostagladin E1 and pentoxifylline. Br J Dermatol 1998; 139 (6):1124-1126
    • (1998) Br J Dermatol , vol.139 , Issue.6 , pp. 1124-1126
    • Kido, M.1    Togo, O.2    Fujiwara, H.3    Ito, M.4    Niwano, H.5
  • 4
    • 0037365587 scopus 로고    scopus 로고
    • Hydroxyurea-induced foot ulcer successfully treated with a topical basic fibroblast growth factor product
    • Aragane Y, Okamoto T, Yajima A, Isogai R, Kawada A, Tezuka T: Hydroxyurea-induced foot ulcer successfully treated with a topical basic fibroblast growth factor product. Br J Dermatol 2003; 148 (3):599-600
    • (2003) Br J Dermatol , vol.148 , Issue.3 , pp. 599-600
    • Aragane, Y.1    Okamoto, T.2    Yajima, A.3    Isogai, R.4    Kawada, A.5    Tezuka, T.6
  • 5
    • 0033566789 scopus 로고    scopus 로고
    • Successful healing of hydroxyurea-related leg ulcers with topical granulocyte-macrophage colony-stimulating factor
    • Stagno F, Guglielmo P, Consoli U, Fiumara P, Russo M, Giustolisi R: Successful healing of hydroxyurea-related leg ulcers with topical granulocyte-macrophage colony-stimulating factor. Blood 1999; 94 (4):1479-1480
    • (1999) Blood , vol.94 , Issue.4 , pp. 1479-1480
    • Stagno, F.1    Guglielmo, P.2    Consoli, U.3    Fiumara, P.4    Russo, M.5    Giustolisi, R.6
  • 6
    • 27744434435 scopus 로고    scopus 로고
    • Locally applied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient
    • Humpert PM, Bartsch U, Konrade I et al.: Locally applied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient. Exp Clin Endocrinol Diabetes 2005; 113 (9):538-540
    • (2005) Exp Clin Endocrinol Diabetes , vol.113 , Issue.9 , pp. 538-540
    • Humpert, P.M.1    Bartsch, U.2    Konrade, I.3
  • 7
    • 1642415178 scopus 로고    scopus 로고
    • Clinical hyperbaric oxygen therapy, wound perfusion, and transcutaneous oximetry
    • Niinikoski JH: Clinical hyperbaric oxygen therapy, wound perfusion, and transcutaneous oximetry. World J Surg 2004; 28 (3):307-311
    • (2004) World J Surg , vol.28 , Issue.3 , pp. 307-311
    • JH, N.1
  • 8
    • 12444302219 scopus 로고    scopus 로고
    • Systematic review of hyperbaric oxygen in the management of chronic wounds
    • Roeckl-Wiedmann I, Bennett M, Kranke P: Systematic review of hyperbaric oxygen in the management of chronic wounds. Br J Surg 2005; 92 (1):24-32
    • (2005) Br J Surg , vol.92 , Issue.1 , pp. 24-32
    • Roeckl-Wiedmann, I.1    Bennett, M.2    Kranke, P.3
  • 10
    • 0032779910 scopus 로고    scopus 로고
    • Hydroxyurea-induced leg ulcers: Is macroerythrocytosis a pathogenic factor?
    • Velez A, Garcia-Aranda JM, Moreno JC: Hydroxyurea-induced leg ulcers: is macroerythrocytosis a pathogenic factor? J Eur Acad Dermatol Venereol 1999; 12 (3):243-244
    • (1999) J Eur Acad Dermatol Venereol , vol.12 , Issue.3 , pp. 243-244
    • Velez, A.1    Garcia-Aranda, J.M.2    Moreno, J.C.3
  • 11
    • 2642595048 scopus 로고    scopus 로고
    • Treatment of myeloproliferative disorders with hydroxyurea: Effects on red blood cell geometry and deformability
    • Engstrom KG, Lofvenberg E: Treatment of myeloproliferative disorders with hydroxyurea: effects on red blood cell geometry and deformability. Blood 1998; 91 (10):3986-3991
    • (1998) Blood , vol.91 , Issue.10 , pp. 3986-3991
    • Engstrom, K.G.1    Lofvenberg, E.2
  • 12
    • 0029912701 scopus 로고    scopus 로고
    • Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study
    • Faglia E, Favales F, Aldeghi A et al.: Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care 1996; 19 (12):1338-1343
    • (1996) Diabetes Care , vol.19 , Issue.12 , pp. 1338-1343
    • Faglia, E.1    Favales, F.2    Aldeghi, A.3
  • 13
    • 0023198225 scopus 로고
    • Hyperbaric oxygen in diabetic gangrene treatment
    • Baroni G, Porro T, Faglia E et al.: Hyperbaric oxygen in diabetic gangrene treatment. Diabetes Care 1987; 10 (1):81-86
    • (1987) Diabetes Care , vol.10 , Issue.1 , pp. 81-86
    • Baroni, G.1    Porro, T.2    Faglia, E.3
  • 14
    • 0043025574 scopus 로고    scopus 로고
    • Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: A prospective randomized study
    • Kessler L, Bilbault P, Ortega F et al.: Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study. Diabetes Care 2003; 26 (3):2378-2382
    • (2003) Diabetes Care , vol.26 , Issue.3 , pp. 2378-2382
    • Kessler, L.1    Bilbault, P.2    Ortega, F.3
  • 15
    • 0036125661 scopus 로고    scopus 로고
    • Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long-term follow-up
    • Kalani M, Jorneskog G, Naderi N, Lind F, Brismar K: Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long-term follow-up. J Diabetes Complications 2002; 16 (2):153-158
    • (2002) J Diabetes Complications , vol.16 , Issue.2 , pp. 153-158
    • Kalani, M.1    Jorneskog, G.2    Naderi, N.3    Lind, F.4    Brismar, K.5
  • 16
    • 15244351264 scopus 로고    scopus 로고
    • Healing times and prediction of wound healing in neuropathic diabetic foot ulcers: A prospective study
    • Zimny S, Pfohl M: Healing times and prediction of wound healing in neuropathic diabetic foot ulcers: a prospective study. Exp Clin Endocrinol Diabetes 2005; 113 (2):90-93
    • (2005) Exp Clin Endocrinol Diabetes , vol.113 , Issue.2 , pp. 90-93
    • Zimny, S.1    Pfohl, M.2
  • 17
    • 0023017591 scopus 로고
    • Unusual dermatologie toxicity of long-term therapy with hydroxyurea in chronic myelogenous leukemia
    • Montefusco E, Alimena G, Gastaldi R, Carlesimo OA, Valesini G, Mandelli F: Unusual dermatologie toxicity of long-term therapy with hydroxyurea in chronic myelogenous leukemia. Tumori 1986; 72 (3):317-321
    • (1986) Tumori , vol.72 , Issue.3 , pp. 317-321
    • Montefusco, E.1    Alimena, G.2    Gastaldi, R.3    Carlesimo, O.A.4    Valesini, G.5    Mandelli, F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.